![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2014
Baraliakos, X.; Heldmann, F.; Callhoff, J.; Listing, J.; Appelboom, T.; Brandt, J.; Bosch, Frank van den; Breban, M.; Burmester, G. R.; Dougados, M.; Emery, P.; Gaston, H.; Grunke, M.; Horst-Bruinsma, I. E. van der; Landewe, R.; Leirisalo-Repo, M.; Sieper, J.; De Vlam, K.; Pappas, D.; Kiltz, U.; Heijde, D. van der und Braun, J.
(Oktober 2014):
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography.
In: Annals of the rheumatic diseases, Bd. 73, Nr. 10: S. 1819-1825
[PDF, 2MB]
2008
Braun, J.; Baraliakos, X.; Listing, J.; Fritz, C.; Alten, R.; Burmester, G.; Krause, A.; Schewe, Stefan; Schneider, M.; Sörensen, H.; Zeidler, H. und Sieper, J.
(2008):
Persistent clinical efficacy and safety of anti-tumour necrosis factor \textgreeka therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
In: Annals of the Rheumatic Diseases, Bd. 67, Nr. 3: S. 340-345
[PDF, 289kB]
2005
Baraliakos, X.; Listing, J.; Brandt, J.; Zink, A.; Alten, R.; Burmester, G.; Gromnica-Ihle, E.; Kellner, H.; Schneider, M.; Sorensen, H.; Zeidler, H.; Rudwaleit, M.; Sieper, J. und Braun, J.
(2005):
Clinical response to withdrawal of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab (vol 7, pg R439, 2005).
In: Arthritis Research & Therapy
7
[PDF, 25kB]